NASDAQ:HROWL Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) Stock Price, News & Analysis → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free HROWL Stock Alerts $24.79 +0.07 (+0.28%) (As of 05/14/2024 ET) Add Compare Share Share Today's Range$24.75▼$24.8550-Day Range$24.22▼$25.2452-Week Range$22.05▼$25.40Volume9,341 shsAverage Volume5,556 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendFinancialsSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendFinancialsSEC FilingsShort InterestSocial Media Get Harrow Health, Inc. 8.625% Senior Notes due 2026 alerts: Email Address Ad Stansberry ResearchHUGE BUY ALERT: Move Fast, Musk...I recently traveled to Phoenix, Arizona...And based on what I saw out there, I'm prepared to put my reputation on the line. Since 2018, my investment recommendations have averaged 115% per year. But one investment I've just discovered could blow them all away.You won't believe what I saw in Phoenix. About Harrow Health, Inc. 8.625% Senior Notes due 2026 Stock (NASDAQ:HROWL)harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. its products portfolio includes topical eye drop drug candidates, including surf-100 and surf-200; surf-300, an oral capsule for treating patients suffering from ocular surface diseases, and ded signs and symptoms; klarity drops to protect and rehabilitate the ocular surface pathology for patients with ded; melt-100, a drug that is administered sublingually for conscious sedation during cataract surgery; may-66 that is used for the treatment of symptoms associated with peyronie's diseasRead More HROWL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HROWL Stock News HeadlinesApril 21, 2024 | wsj.comHarrow Inc. 8.625% Sr. Notes due 2026February 22, 2024 | benzinga.comHarrow, Inc. - 8.625% senior notes due 2026 Stock (NASDAQ:HROWL) Dividends: History, Yield and DatesFebruary 5, 2024 | seekingalpha.comHarrow: Hedge Downside Risk With The 11.5% Yielding Baby BondsSee More Headlines Receive HROWL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Harrow Health, Inc. 8.625% Senior Notes due 2026 and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 4/30 Dividend4/12/2024Dividend Payable4/30/2024Today5/14/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Sector-- Industry - Sub-IndustryN/A Current SymbolNASDAQ:HROWL CUSIPN/A CIK1360214 WebN/A PhoneN/AFaxN/AEmployees22Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key CompetitorsAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028NASDAQ:ABLLLAbrdn Global Infrastructure Income FundNYSE:ASGIAimei Health TechnologyNASDAQ:AFJKRAlphaTime AcquisitionNASDAQ:ATMCRArgo Blockchain plc 8.75% Senior Notes due 2026NASDAQ:ARBKLView All Competitors HROWL Stock Analysis - Frequently Asked Questions How have HROWL shares performed in 2024? Harrow Health, Inc. 8.625% Senior Notes due 2026's stock was trading at $23.95 at the start of the year. Since then, HROWL stock has increased by 3.5% and is now trading at $24.79. View the best growth stocks for 2024 here. How often does Harrow Health, Inc. 8.625% Senior Notes due 2026 pay dividends? What is the dividend yield for Harrow Health, Inc. 8.625% Senior Notes due 2026? Harrow Health, Inc. 8.625% Senior Notes due 2026 declared a quarterly dividend on Friday, April 12th. Investors of record on Monday, April 15th will be paid a dividend of $0.5391 per share on Tuesday, April 30th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 8.70%. The ex-dividend date of this dividend is Friday, April 12th. Read our dividend analysis for HROWL. How do I buy shares of Harrow Health, Inc. 8.625% Senior Notes due 2026? Shares of HROWL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HROWL) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harrow Health, Inc. 8.625% Senior Notes due 2026 Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.